Cargando…

Critical commentary on the association between thiazolidinedione use and dementia risk in patients with type 2 diabetes

Detalles Bibliográficos
Autores principales:	Wasif, Uzayr, Al‐Shehab, Usmaan, Lo, David F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wiley Publishing Asia Pty Ltd 2023
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10345971/ https://www.ncbi.nlm.nih.gov/pubmed/37157122 http://dx.doi.org/10.1111/1753-0407.13409

Ejemplares similares

Response to: Critical commentary on the association between thiazolidinedione use and dementia risk in patients with type 2 diabetes
por: Zhao, Houyu, et al.
Publicado: (2023)

Association of serum sodium levels and diabetes: A critical analysis
por: Al‐Shehab, Usmaan, et al.
Publicado: (2023)

Use of portable air purifiers to reduce aerosols in hospital settings and cut down the clinical backlog: a critical analysis
por: Malek, Robert, et al.
Publicado: (2023)

Thiazolidinediones: the Forgotten Diabetes Medications
por: Lebovitz, Harold E.
Publicado: (2019)

Thiazolidinediones lower the risk of pneumonia in patients with type 2 diabetes
por: Yen, Fu-Shun, et al.
Publicado: (2023)

Type 2 Diabetes: Uses of thiazolidinediones and insulin
por: T. Bloomgarden, Zachary
Publicado: (2011)

Thiazolidinedione use is associated with reduced risk of dementia in patients with type 2 diabetes mellitus: A retrospective cohort study
por: Zhao, Houyu, et al.
Publicado: (2023)

Redefining the role of thiazolidinediones in the management of type 2 diabetes
por: Barnett, Anthony H
Publicado: (2009)

Thiazolidinedione use and risk of Parkinson’s disease in patients with type 2 diabetes mellitus
por: Zhao, Houyu, et al.
Publicado: (2022)

Glucose excursions in type 2 diabetes modulate amyloid-related proteins associated with dementia
por: Moin, Abu Saleh Md, et al.
Publicado: (2021)

An Update on the Current and Emerging Use of Thiazolidinediones for Type 2 Diabetes
por: Giglio, Rosaria Vincenza, et al.
Publicado: (2022)

Commentary on “The association between sexual function and prostate cancer risk in US veterans”
por: Wang, Kai, et al.
Publicado: (2018)

Commentary on: Is uric acid an indicator of metabolic syndrome in the first-degree relatives of patients with type 2 diabetes?
por: Nasri, Hamid
Publicado: (2013)

Re: Commentary on “The association between sexual function and prostate cancer risk in US veterans”
por: Vidal, Adriana C, et al.
Publicado: (2018)

Treatment update: thiazolidinediones in combination with metformin for the treatment of type 2 diabetes
por: Stafford, John M, et al.
Publicado: (2007)

Lobeglitazone: A Novel Thiazolidinedione for the Management of Type 2 Diabetes Mellitus
por: Bae, Jaehyun, et al.
Publicado: (2021)

Risk of Fracture with Thiazolidinediones: Disease or Drugs?
por: Bazelier, Marloes T., et al.
Publicado: (2012)

Commentary: Barotrauma in critically ill patients with COVID-19: miles to go to unwrap the pathophysiology
por: Bhattacharya, Dipasri, et al.
Publicado: (2023)

Commentary on: Effects of Cinnamon Consumption on Glycemic Status, Lipid Profile and Body Composition in Type 2 Diabetic Patients
por: Nasri, Hamid, et al.
Publicado: (2013)

Commentary
por: Wildenauer, René
Publicado: (2013)

Commentary
por: Emami, Mehrdad
Publicado: (2015)

Commentary
por: Curtò, Lorenzo
Publicado: (2015)

Commentary
por: Menon, Girish
Publicado: (2017)

Commentary
por: Mohammed, Wail
Publicado: (2019)

Commentary
por: Satyarthee, Guru Dutta
Publicado: (2019)

Commentary
por: Das, Dilip Kumar
Publicado: (2019)

Commentary
por: Chaturvedi, Sujata
Publicado: (2019)

Internet addiction among young Bangladeshi adults: critical commentary on Hassan et al. (2020)
por: Griffiths, Mark D., et al.
Publicado: (2020)

Commentary on “high-risk behavior in patients with alcohol dependence”
por: Praharaj, Samir Kumar
Publicado: (2019)

Thiazolidinediones and the risk of asthma exacerbation among patients with diabetes: a cohort study
por: Rinne, Seppo T, et al.
Publicado: (2014)

Critical Comment on Depression in Main Caregivers of Dementia Patients: Prevalence and Predictors
por: Saini, Radha, et al.
Publicado: (2018)

Dementia and the Risk of Hip Fracture
por: Lai, Shih-Wei
Publicado: (2020)

Thiazolidinedione Use in Individuals With Type 2 Diabetes and Chronic Obstructive Pulmonary Disease
por: Yen, Fu-Shun, et al.
Publicado: (2021)

Thiazolidinedione derivatives as novel GPR120 agonists for the treatment of type 2 diabetes
por: Wang, Xuekun, et al.
Publicado: (2022)

Commentary on – “Comparison of the efficacy and safety of once-daily dosing and on-demand use of udenafil for type 2 diabetic patients with erectile dysfunction”
por: Cao, De-Hong, et al.
Publicado: (2015)

Chemotherapy and Chemoprevention by Thiazolidinediones
por: Fröhlich, Eleonore, et al.
Publicado: (2015)

Thiazolidinediones and bone fractures
por: Kaku, Kohei, et al.
Publicado: (2011)

Thiazolidinediones and Cardiovascular Risk — A Question of Balance
por: Erdmann, Erland, et al.
Publicado: (2009)

Thiazolidinediones and Edema: Recent Advances in the Pathogenesis of Thiazolidinediones-Induced Renal Sodium Retention
por: Horita, Shoko, et al.
Publicado: (2015)

Response to Commentary: Treating Alzheimer Dementia With CT-Induced Low-Dose Ionizing Radiation: Problematic, Yet Potential for More Precise Inquiry
por: Cuttler, Jerry M.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_p48ej95e0roos17o19mpl2senf